[1]Wang H, Yang H, Tracey KJ.Extracellular role of HMGB1 in in-flammation and sepsis[J].J Intern Med, 2004, 255 (3) :320-331.
|
[2]赵雷, 刘靖华, 唐靖, 等.人高迁移率族蛋白1的原核细胞表达及其功能研究[J].中国病理生理杂志, 2006, 22 (6) :1119-1123.
|
[3] 中华医学会.慢性乙型肝炎防治指南[J].胃肠病学, 2006, 11 (9) :550-556.
|
[4]中华医学会.病毒性肝炎防冶方案[J].中华肝脏病杂志, 2000, 8 (3) :324-329.
|
[5]Ishak K, Bap tista A, Bianchi L, et al.Histological grading andstaging of chronic hepatitis[J].J Hepatol, 1995, 22 (4) :696-699.
|
[6]Koichi S, Hiroya T, Akitoshi I, et al.High-mobility-group boxchromosomal protein 1 as a new target for modulating stress response[J].Surg Today, 2010, 40 (4) :592-601.
|
[7]Hamada N, Maeyama T, Kawaguchi T, at al.The role of high mob-ility group box 1 in pulmonary fibrosis[J].Am J Respir Cell MolBiol, 2008, 39 (2) :440-447.
|
[8]赵中夫, 韩德五.高迁移率族蛋白B-1及其在肝损伤合并内毒素血症中的作用[J].中华肝脏病杂志, 2006, 14 (9) :718-720.
|
[9]刘洪波, 范学工, 黄建军, 等.乙型肝炎患者血清高迁移率蛋白-1含量的检测及临床意义[J].中华肝脏病杂志, 2007, 15 (11) :812-815.
|
[10]刘洪波, 范学工, 刘悦晖, 等.肝损伤模型小鼠高迁移率族蛋白-1的表达[J].生命科学研究, 2008, 12 (2) :169-173.
|
[11]Ayse A, Muhammet HU, Serkan C, et al.Is HMGB1 a new indi-rect marker for revealing fibrosis in chronic hepatitis and a new ther-apeutic target in treatment[J].Viral Immunol, 2010, 23 (6) :633-638.
|
[12]Kao, Jawan B, Goto S, et al.High-mobility group box 1 pro-tein activates hepatic stellate cells in vitro[J].Transplant Proc, 2008, 40 (8) :2704-2705.
|
[13]Sitia G, Iannacone M, Muller S, et al.Treatment with HMGB1 inhibi-tors diminishes CTL-induced liver disease in HBV transgenic mice[J].J Leukoc Biol, 2007, 81 (1) :100-107.
|
[14]Jon C, Pinhua P, Rajeev D, et al.Cisplatin prevents high mobilitygroup box 1 release and is protective in a murine model of hepatic is-chemia/reperfusion injury[J].Hepatology, 2009, 50 (2) :565-574.
|
[15] Koichi S, Hiroya T, Akitoshi I, et al.High-mobility-group boxchromosomal protein 1 as a new target for modulating stress response[J].Surg Today, 2010, 40 (3) :592-601.
|